Subscribe to RSSBiotechnology
Watch breaking news videos and read news updates about Biotechnology on FOXBusiness.com.
LATEST VIDEOS
N.Y. Republican Congressman Vito Fossella on how the health bills might be combined.
We break down whether October's numbers are a sign of the return of the retailer.
Too Many Cooks in D.C.'s Kitchen?
11/11/2009|Web Exclusive
We break down whether the government has made life too complicated.
Google CEO: Recession is Behind Us
11/05/2009|Cavuto
Google CEO Eric Schmidt on why technology is a driving force in the economic recovery.
Software Spots a Potential Thief
10/27/2009|Web Exclusive
We bring you the latest technological innovation that is changing the way criminals are detected.
Who Wants to Be Governor of California?
10/20/2009|Bulls and Bears
San Francisco Mayor Gavin Newsom on why he wants to lead the nation's biggest economic powerhouse.
We break down if inflation will be the next economic hurtle to cross the recovery line.
We break down if Wall Street's biggest titans are actually on the road to recovery.
Onyx CEO on the Proteolix Deal
10/12/2009|Opening Bell
Onyx Pharmaceuticals CEO Tony Coles on the pharmaceutical company's purchase of Proteolix for $276 million.
We break down if the government is getting ready to cap the nation's biggest earners.
LATEST STORIES
Drug Stocks Cling To Flat Line; Poniard Falls
| MarketWatch Pulse| Markets
… Pharmaceuticals slid for the second day. The NYSE Arca Pharmaceutical Index was down marginally at 301.14 while the NYSE Arca Biotechnology Index was up nominally at 870.85. Shares of Poniard fell 5% to $2.25. The stock rocketed earlier in the week following …
Story|11/20/2009
Allergan, Medicis Lead Drug Stocks Lower
| MarketWatch Pulse| Markets
… Senate Democrats would levy a 5% excise tax on cosmetic procedures. The NYSE Arca Pharmaceutical Index and the NYSE Arca Biotechnology Index were both down 1.4% at 298.94 and 872.60, respectively. Shares of Allergan were down 3% at $58.15, while …
Story|11/19/2009
Vivus Shares Rise on Erectile Dysfunction Drug Success
| FOXBusiness| Markets
… VVUS) shares rose Wednesday on news that its erectile dysfunction drug was effective in a late stage trial, putting the biotech firm on course to file an application with the Food and Drug Administration in 2011. The shares were up about 3% in late …
Story|11/18/2009
Drug Stocks Mixed; Vivus Jumps On Study
| MarketWatch Pulse| Markets
… for its new erectile dysfunction drug. The NYSE Arca Pharmaceutical Index advanced nominally to 301.81 as the NYSE Arca Biotechnology Index declined 0.8% to 889.64. Vivus shares climbed 9% to $9.31. Copyright © 2009 MarketWatch, Inc.
Story|11/18/2009
InterMune Shares Fall on Drug Study
| FOXBusiness| Markets
… conducting a study of its hepatitis C drug, said it would discontinue studying a high level dose amid fears of liver damage. The biotech firm said an independent monitoring committee recommended the company discontinue testing its 900 milligram dose in a mid …
Story|11/17/2009
Drug Stocks Dip; Alkermes Gains For Second Day
| MarketWatch Pulse| Markets
… about two of its substance-abuse therapies. The NYSE Arca Pharmaceutical Index fell 0.6% to 300.7 and the NYSE Arca Biotechnology Index declined 0.7% to 896.23. Alkermes shares were up 10% at $9.02. Copyright © 2009 MarketWatch, Inc.
Story|11/17/2009
FDA Finds Deficiencies at Genzyme's Lumizyme Plant
| FOXBusiness| Markets
… By Kathryn Glass FOXBusiness Cambridge, Mass.-based biotech firm Genzyme Corp. (GENZ) announced Monday that it had been notified by the U.S. Food & Drug Administration of new deficiencies …
Story|11/16/2009
Merck, Bristol-Myers Lead Drug Stocks Higher
| MarketWatch Pulse| Markets
… joining the broader market in positive territory. The NYSE Arca Pharmaceutical Index rose 1% to 300.82 and the NYSE Arca Biotechnology Index edged up 0.4% to 895.04. Shares of Merck were up 3% at $34.24, while Bristol-Myers shares gained 4 …
Story|11/16/2009
Early-Market Movers: Sprint Nextel, Citigroup
| FOXBusiness| Markets
… Suisse raised their rating to “outperform” from “neutral.” Shares were up 9.3% in pre-market trading. Sinovac Biotech Ltd. (SVA) The company announced it was selected by the Shanghai Government to supply its Healive hepatitis A vaccine to …
Story|11/16/2009
Women Stake a Claim in Clean Tech
| WomenEntrepreneur.com| Personal Finance
… out that women have a successful track record for running biotech firms in pharma and personal products as well as for running ..... sciences or clean tech startups. Women in BIO. For women in biotechnology or life sciences businesses. WITI, Women in Technology International …
Story|11/16/2009
